Trial Details

COMPLETED
Basic Information
Clinical ID c1651
Identifier NCT04741087
Trial Title Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Pouchitis
Interventions DRUG: AMT-101 (oral)-Dose A|DRUG: AMT-101 (oral)-Dose B
Participant Information
Sponsor Applied Molecular Transport
City Bristol
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-02-05
Primary Completion Date 2022-03-11
Completion Date 2022-04-22